Drug interactions
Adalimumab + Meningococcal a c y and w-135 polysaccharide vaccine combined
Severity: Moderate
Adalimumab and Meningococcal a c y and w-135 polysaccharide vaccine combined: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Adalimumab may lessen the antibody response to this inactivated meningococcal vaccine, reducing protection.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Adalimumab and Meningococcal a c y and w-135 polysaccharide vaccine combined interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Free 14-day trial. No card needed.
Other interactions of Adalimumab
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
